Literature DB >> 22533889

Organ-specific management and supportive care in chronic graft-versus-host disease.

Fiona L Dignan1, Julia J Scarisbrick, Jacqueline Cornish, Andrew Clark, Persis Amrolia, Graham Jackson, Prem Mahendra, Peter C Taylor, Pallav Shah, Sue Lightman, Farida Fortune, Christopher Kibbler, Jervoise Andreyev, Assunta Albanese, Nedim Hadzic, Michael N Potter, Bronwen E Shaw.   

Abstract

A joint working group established by the Haemato-oncology subgroup of the British Committee for Standards in Haematology and the British Society for Bone Marrow Transplantation has reviewed the available literature and made recommendations for the supportive care and management of organ-specific complications of chronic graft-versus-host disease (cGvHD). This guideline includes recommendations for the specific therapy of skin, oral, liver, gut, lung, ocular and genital manifestations of cGvHD and for the supportive care of these patients, including vaccinations and prophylaxis against infection. The goal of treatment should be effective control of GvHD while minimizing the risk of toxicity and relapse.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22533889     DOI: 10.1111/j.1365-2141.2012.09131.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  17 in total

Review 1.  Palliative care during and following allogeneic hematopoietic stem cell transplantation.

Authors:  Sandra A Mitchell
Journal:  Curr Opin Support Palliat Care       Date:  2018-03       Impact factor: 2.302

2.  Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers.

Authors:  Sharon Elad; Siri Beier Jensen; Judith E Raber-Durlacher; Nancy Mouradian; Elvira M P Correa; Mark M Schubert; Nicole M A Blijlevens; Joel B Epstein; Deborah P Saunders; Tuomas Waltimo; Noam Yarom; Yehuda Zadik; Michael T Brennan
Journal:  Support Care Cancer       Date:  2014-11-23       Impact factor: 3.603

Review 3.  Treatment and management of graft-versus-host disease: improving response and survival.

Authors:  Catherine Garnett; Jane F Apperley; Jiří Pavlů
Journal:  Ther Adv Hematol       Date:  2013-12

4.  A cross-sectional study on vision-related quality of life in patients with ocular GvHD.

Authors:  S Pezzotta; G C Rossi; L Scudeller; E Antoniazzi; P E Bianchi; C Perotti; C Del Fante
Journal:  Bone Marrow Transplant       Date:  2015-06-08       Impact factor: 5.483

Review 5.  What else do I need to worry about when treating graft-versus-host disease?

Authors:  Areej El-Jawahri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 6.  Allogenic stem cell transplant-associated acute graft versus host disease: a computational drug discovery text mining approach using oral and gut microbiome signatures.

Authors:  M F Beckman; D S Morton; F Bahrani Mougeot; J-L C Mougeot
Journal:  Support Care Cancer       Date:  2020-10-22       Impact factor: 3.603

7.  Prevalence and determinants of fatigue in patients with moderate to severe chronic GvHD.

Authors:  A Im; S A Mitchell; S M Steinberg; L Curtis; A Berger; K Baird; Z Kuzmina; G Joe; L E Comis; M Juckett; D Avila; J Baruffaldi; L Masuch; F Pirsl; S Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2016-02-01       Impact factor: 5.483

Review 8.  Graft-versus-host disease affecting oral cavity. A review.

Authors:  Maria Margaix-Muñoz; José V Bagán; Yolanda Jiménez; María-Gracia Sarrión; Rafael Poveda-Roda
Journal:  J Clin Exp Dent       Date:  2015-02-01

9.  A systematic review of rehabilitation and exercise recommendations in oncology guidelines.

Authors:  Nicole L Stout; Daniel Santa Mina; Kathleen D Lyons; Karen Robb; Julie K Silver
Journal:  CA Cancer J Clin       Date:  2020-10-27       Impact factor: 508.702

10.  International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I).

Authors:  Yoko Ogawa; Stella K Kim; Reza Dana; Janine Clayton; Sandeep Jain; Mark I Rosenblatt; Victor L Perez; Hasanain Shikari; Anjo Riemens; Kazuo Tsubota
Journal:  Sci Rep       Date:  2013-12-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.